BRCA1 185delAG mutation inhibits Akt-dependent, 1AP-mediated caspase 3 inactivation in human ovarian surface epithelial cells

被引:21
作者
Johnson, NC
Dan, HC
Cheng, JQ
Kruk, PA
机构
[1] Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33612 USA
关键词
BRCA1; apoptosis; Akt; XIAP; caspase; 3; hereditary ovarian cancer;
D O I
10.1016/j.yexcr.2004.04.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BRCA1 mutations have long been associated with altered apoptosis. We have recently reported that caspase 3 activation is increased in human ovarian surface epithelial (OSE) cells expressing a germline N-terminal BRCA1 185delAG mutation. Here, we report increased caspase 3 activity in 185delAG OSE cells associated with decreased expression of cIAP-1 and X-linked inhibitor of apoptosis (XIAP), and decreased ubiquitination of caspase 3. Overexpression of XIAP restored active caspase 3 ubiquitination and lowered levels of caspase 3 activity. Further, the BRCA1 185delAG mutation was associated with reduced levels of phosphorylated Akt1 Transfection with activated Akt1 led to increased cIAP-1 and XIAP levels similar to that seen in BRCA1 185delAG cell lines. Taken together, these data suggest a direct link between the BRCA1 185delAG mutation and alterations in the caspase-mediated apoptotic pathway. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 33 条
[1]  
AGNON V, 2003, INT J ONCOL, V23, P803
[2]  
Alfonso-De Matte MY, 2002, CANCER RES, V62, P4575
[3]   Effect of BRCA mutations on the length of survival in epithelial ovarian tumors [J].
Ben David, Y ;
Chetrit, A ;
Hirsh-Yechezkel, G ;
Friedman, E ;
Beck, BD ;
Beller, U ;
Ben-Baruch, G ;
Fishman, A ;
Levavi, H ;
Lubin, F ;
Menczer, J ;
Piura, B ;
Struewing, JP ;
Modan, B .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :463-466
[4]   Apoptosis: checkpoint at the mitochondrial frontier [J].
Bossy-Wetzel, E ;
Green, DR .
MUTATION RESEARCH-DNA REPAIR, 1999, 434 (03) :243-251
[5]   Clinicopathologic features of BRCA-linked and sporadic ovarian cancer [J].
Boyd, J ;
Sonoda, Y ;
Federici, MG ;
Bogomolniy, F ;
Rhei, E ;
Maresco, DL ;
Saigo, PE ;
Almadrones, LA ;
Barakat, RR ;
Brown, CL ;
Chi, DS ;
Curtin, JP ;
Poynor, EA ;
Hoskins, WJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (17) :2260-2265
[6]   Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway [J].
Cheng, JQ ;
Jiang, XX ;
Fraser, M ;
Li, M ;
Dan, HC ;
Sun, M ;
Tsang, BK .
DRUG RESISTANCE UPDATES, 2002, 5 (3-4) :131-146
[7]   Proteases to die for [J].
Cryns, V ;
Yuan, JY .
GENES & DEVELOPMENT, 1998, 12 (11) :1551-1570
[8]   RETRACTED: Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP) (Retracted Article) [J].
Dan, HC ;
Sun, M ;
Kaneko, S ;
Feldman, RI ;
Nicosia, SV ;
Wang, HG ;
Tsang, BK ;
Cheng, JQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (07) :5405-5412
[9]  
Deng CX, 2000, BIOESSAYS, V22, P728
[10]   Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population [J].
Díez, O ;
Domènech, M ;
Alonso, MC ;
Brunet, J ;
Sanz, J ;
Cortés, J ;
del Río, E ;
Baiget, M .
HUMAN GENETICS, 1998, 103 (06) :707-708